Anti-idiotypic response to antigrowth factor receptor monoclonal antibodies

This publication has 23 references indexed in Scilit:

• Anti‐tumor efficacy of an anti‐epidermal‐growth‐factor‐ receptor monoclonal antibody and its F(ab′)₂ fragment against high‐ and low‐egfr‐expressing carcinomas in nude mice
  International Journal of Cancer, 1995
• Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma
  Pharmacology & Therapeutics, 1993
• Idiotypes: structure and immunogenicity ¹
  The FASEB Journal, 1993
• p185 HER2/neu Epitope Mapping with Murine Monoclonal Antibodies
  Hybridoma, 1992
• Growth Factors and Cancer
  Science, 1991
• Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
  International Journal of Cancer, 1991
• Selection of monoclonal antibodies which induce internalization and phosphorylation of P185^HER2 and growth inhibition of cells with HER2/neu gene amplification
  International Journal of Cancer, 1991
• Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers
  British Medical Bulletin, 1991
• Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.
  Journal of Clinical Investigation, 1990
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989